4 studies were found.

1.		No longer recruiting	Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck Conditions: Salivary Gland Cancer; Oral Cancer; Lip Cancer; Head and Neck Cancer; Oropharyngeal Cancer
2.		No longer recruiting	Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Conditions: stage IV non-small cell lung cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; Adenocarcinoma of the Lung; ...
3.		No longer recruiting	Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer
4.		No longer recruiting	Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer Conditions: stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer